Advances in understanding the anti-inflammatory properties of IL-27
- 3 March 2008
- journal article
- review article
- Published by Elsevier in Immunology Letters
- Vol. 117 (2) , 123-130
- https://doi.org/10.1016/j.imlet.2008.01.011
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cellsProceedings of the National Academy of Sciences, 2007
- IL‐27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1European Journal of Immunology, 2007
- TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1Nature Medicine, 2007
- Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-γ–mediated pathwaysThe Journal of Experimental Medicine, 2007
- Alternatively activated macrophages express the IL-27 receptor alpha chain WSX-1Immunobiology, 2006
- Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27The Journal of Experimental Medicine, 2006
- IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6Journal of Clinical Investigation, 2006
- Impaired Th1 responses in mice deficient in Epstein-Barr virus-induced gene 3 and challenged with physiological doses ofLeishmania majorEuropean Journal of Immunology, 2005
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Cloning and Characterization of a Novel Class I Cytokine ReceptorBiochemical and Biophysical Research Communications, 1998